Page 96 - 南京医科大学自然版

第44卷第4期
·534 · 南 京 医 科 大 学 学 报 2024年4月

enhances glucose ⁃ derived de novo serine biosythseis to gy in combating cancer［J］. BioFactors，2022，48（2）：
promote gliblastoma growth［J］. J Exp Clin Cancer Res， 359-383
2023，42（1）：340 ［49］ZHAO F Y，YANG G，QIU J D，et al. HIF⁃1α⁃regulated
［38］FAN K，FAN Z Y，CHENG H，et al. Hexokinase 2 dimeri⁃ stanniocalcin⁃ 1 mediates gemcitabine resistance in pan⁃
zation and interaction with voltage⁃dependent anion chan⁃ creatic ductal adenocarcinoma via PI3K/AKT signaling
nel promoted resistance to cell apoptosis induced by gem⁃ pathway［J］. Mol Carcinog，2022，61（9）：839-850
citabine in pancreatic cancer［J］. Cancer Med，2019，8 ［50］XI Y，YUAN P，LI T，et al. hENT1 reverses chemoresis⁃
（13）：5903-5915 tance by regulating glycolysis in pancreatic cancer［J］.
［39］XIE P，TAN S Y，LI H F，et al. Transcriptome data⁃based Cancer Lett，2020，479：112-122
status of PI3K/AKT/mTOR pathway indicates heterogene⁃ ［51］LIU Y，GU Y J，NG S，et al. Circulating levels of hydroxyl⁃
ity and immune modulation in patients with pancreatic ated bradykinin function as an indicator of tissue HIF⁃1α
ductal adenocarcinoma［J］. J Gene Med，2024，26（1）： expression［J］. Sci Bull，2020，65（18）：1570-1579
e3570 ［52］SHUKLA S K，PUROHIT V，MEHLA K，et al. MUC1 and
［40］CHENG L，QIN T，MA J G，et al. Hypoxia⁃inducible factor⁃ HIF⁃1alpha signaling crosstalk induces anabolic glucose
1α mediates hyperglycemia ⁃ induced pancreatic cancer metabolism to impart gemcitabine resistance to pancreatic
glycolysis［J］. Anticancer Agents Med Chem，2019，19 cancer［J］. Cancer Cell，2017，32（3）：392
（12）：1503-1512 ［53］XU F Y，HUANG M Q，CHEN Q Y，et al. LncRNA HIF1A⁃
［41］PENNY H L，SIEOW J L，ADRIANI G，et al. Warburg me⁃ AS1 promotes gemcitabine resistance of pancreatic can⁃
tabolism in tumor⁃conditioned macrophages promotes me⁃ cer by enhancing glycolysis through modulating the AKT/
tastasis in human pancreatic ductal adenocarcinoma［J］. YB1/HIF1α pathway［J］. Cancer Res，2021，81（22）：
Onco Immunology，2016，5（8）：e1191731 5678-5691
［42］OZCAN S C，SARIOGLU A，ALTUNOK T H，et al. ［54］GAO C T，LI S S，ZHAO T S，et al. SCF，regulated by HIF⁃
PFKFB2 regulates glycolysis and proliferation in pancre⁃ 1α，promotes pancreatic ductal adenocarcinoma cell pro⁃
atic cancer cells［J］. Mol Cell Biochem，2020，470（1/2）： gression［J］. PLoS One，2015，10（3）：e0121338
115-129 ［55］YING H Q，KIMMELMAN A C，LYSSIOTIS C A，et al.
［43］MINCHENKO O H，TSUCHIHARA K，MINCHENKO D O， Oncogenic KRAS maintains pancreatic tumors through
et al. Mechanisms of regulation of PFKFB expression in regulation of anabolic glucose metabolism［J］. Cell，2012，
pancreatic and gastric cancer cells［J］. World J Gastroen⁃ 149（3）：656-670
terol，2014，20（38）：13705-13717 ［56］LI Y G，TANG S J，SHI X H，et al. Metabolic classifica⁃
［44］LI H M，YANG J G，LIU Z J，et al. Blockage of glycolysis tion suggests the GLUT1/ALDOB/G6PD axis as a therapeu⁃
by targeting PFKFB3 suppresses tumor growth and metas⁃ tic target in chemotherapy⁃resistant pancreatic cancer［J］.
tasis in head and neck squamous cell carcinoma［J］. J Cell Rep Med，2023，4（9）：101162
Exp Clin Cancer Res，2017，36（1）：7 ［57］LI X J，JIANG Y H，MEISENHELDER J，et al. Mitochon⁃
［45］CHRISTOFK H R，VANDER HEIDEN M G，HARRIS M H， dria⁃translocated PGK1 functions as a protein kinase to co⁃
et al. The M2 splice isoform of pyruvate kinase is impor⁃ ordinate glycolysis and the TCA cycle in tumorigenesis［J］.
tant for cancer metabolism and tumour growth［J］. Nature， Mol Cell，2016，61（5）：705-719
2008，452（7184）：230-233 ［58］WU D H，LIANG H，LU S N，et al. MiR⁃124 suppresses
［46］CALABRETTA S，BIELLI P，PASSACANTILLI I，et al. pancreatic ductal adenocarcinoma growth by regulating
Modulation of PKM alternative splicing by PTBP1 pro⁃ monocarboxylate transporter 1 ⁃ mediated cancer lactate
motes gemcitabine resistance in pancreatic cancer cells［J］. metabolism［J］. Cell Physiol Biochem，2018，50（3）：924-
Oncogene，2016，35（16）：2031-2039 935
［47］FENG J K，MA T L，GE Z J，et al. PKM2 gene regulates ［59］KONG S C，NØHR ⁃ NIELSEN A，ZEEBERG K，et al.
the behavior of pancreatic cancer cells via mitogen⁃acti⁃ Monocarboxylate transporters MCT1 and MCT4 regulate
vated protein kinase pathways［J］. Mol Med Rep，2015，11 migration and invasion of pancreatic ductal adenocarcino⁃
（3）：2111-2117 ma cells［J］. Pancreas，2016，45（7）：1036-1047
［48］KOOSHKI L，MAHDAVI P，FAKHRI S，et al. Targeting ［60］KAWADA K，TODA K，SAKAI Y. Targeting metabolic re⁃
lactate metabolism and glycolytic pathways in the tumor programming in KRAS⁃driven cancers［J］. Int J Clin On⁃
microenvironment by natural products：a promising strate⁃ col，2017，22（4）：651-659